STOCK TITAN
  1. Home
  2. Sec-filings
  3. VICR
  4. [144] VICOR CORP SEC Filing

Rule 144: Multiple 10b5-1 sales reported for VICR (VICR)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Morgan Stanley Smith Barney LLC filed a Rule 144 resale notice listing Common stock to be sold and documenting multiple 10b5-1 sales by Patrizio Vinciarelli and several institutional holders. The excerpt lists individual sale dates, share counts, and gross proceeds for each trade.

The filing shows repeated 10b5-1 dispositions by Patrizio Vinciarelli across March–June 2026 (multiple 50,000 and other-size trades) and separate smaller sales by Brigham and Women's Hospital and Lahey Hospital & Medical Center. The submission names Morgan Stanley Smith Barney LLC as the broker/agent and lists 20,000 shares in a separate securities block.

Positive

  • None.

Negative

  • None.

Insights

Filing documents routine Rule 144 resales and scheduled 10b5-1 dispositions.

The excerpt lists numerous 10b5-1 sales by Patrizio Vinciarelli with explicit trade dates, share counts (for example, 50,000 shares on multiple March dates) and gross proceeds per trade. It also names institutional transferees with single entries (e.g., 3,500 shares by Brigham and Women's Hospital).

These entries are procedural resale disclosures; cash‑flow recipients and any trading-plan terms beyond the label "10b5-1" are not detailed in the excerpt. Subsequent filings may provide consolidated totals or further attribution.

Single securities block 20,000 shares listed under Securities To Be Sold
10b5-1 sale example 50,000 shares multiple trades in March 2026 by Patrizio Vinciarelli
Smaller institutional sale 3,500 shares Brigham and Women's Hospital on 05/14/2026
Gross proceeds example $9,809,142.46 one listed trade gross proceeds (example format shown in excerpt)
Recent small sale 20,000 shares 06/05/2026 entry shown in header block
10b5-1 regulatory
"10b5-1 Sales for PATRIZIO VINCIARELLI 06/04/2026 20000"
A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.
Founders Shares market
"Common | 11/10/1981 | Founders Shares | Issuer"
Founders shares are a special block of a company’s stock originally given to the people who started the business; they often carry extra voting power or favorable terms compared with regular shares. For investors, these shares matter because they concentrate control and influence how future funding, ownership dilution, and decision-making will play out—think of founders shares as the steering wheel that can steer a company’s direction even as more passengers (investors) climb aboard.
Rule 144 regulatory
"144: Securities To Be Sold"
Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Source: View Original Filing on SEC EDGAR

FAQ

What does the VICR filing show about 10b5-1 sales?

The filing lists multiple 10b5-1 sales by Patrizio Vinciarelli with trade dates and gross proceeds for each transaction, covering March through June 2026 and including several 50,000-share trades.

Who is the broker listed on the Rule 144 filing for VICR?

The filing names Morgan Stanley Smith Barney LLC as the broker/agent, with an address at 1 New York Plaza, 8th Floor, New York, NY, associated with the listed resale activity.

Which institutional holders appear in the VICR resale entries?

The excerpt shows sales attributed to Brigham and Women's Hospital and Lahey Hospital & Medical Center, each with an entry of 3,500 shares on 05/14/2026 and listed gross proceeds.

Does the filing state the total aggregate proceeds from the sales?

The filing provides gross proceeds for each listed trade (for example, $9,805,142.46 for certain entries) but does not present an explicit consolidated aggregate total in the provided excerpt.

Are the trades labeled as pre‑arranged or plan trades in the VICR excerpt?

Many entries are labeled 10b5-1 Sales, indicating they were made under a trading plan; the excerpt does not include the plan documentation or its effective dates.